Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474592 | SCV000562020 | benign | Hereditary pancreatitis | 2024-01-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000474592 | SCV001471910 | likely benign | Hereditary pancreatitis | 2020-03-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000474592 | SCV002646910 | uncertain significance | Hereditary pancreatitis | 2014-09-15 | criteria provided, single submitter | clinical testing | The c.494-6C>T intronic variant results from a C to T substitution 6 nucleotides upstream from coding exon 6 in the CTRC gene. This variant was previously reported in the SNPDatabase as rs111790169. Based on data from the NHLBI Exome Sequencing Project (ESP), the T allele has an overall frequency of approximately 0.12% (15/13006) total alleles studied, having been observed in 0.34% (15/4406) African American alleles. This nucleotide position is well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this acceptor; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |